Sepsis risk Low revenue but high impact opportunity in hospital systems and ASPs seeking to reduce catheter-related sepsis. Target large medical centers and integrated delivery networks with emphasis on catheter care protocols and infection control.

Clinical efficacy Strong value proposition around reducing catheter-associated infections. Position PrevaCept Lock Solution as a cost-saving, patient-safety improvement that can support fall-back on reduced sepsis rates and shorter hospital stays.

Funding leverage Recent $18M funding suggests a growth trajectory; leverage investor narrative to engage strategic buyers and procurement teams. Highlight potential scale, clinical adoption speed, and competencies to win long-term contracts.

Tech readiness Existing tech stack shows digital tracking and analytics capabilities. Use data-driven sales approach to demonstrate measurable outcomes and align with hospital dashboards and reporting requirements.

Market positioning Competitively positioned among large players with a focus on infection control. Target mid-to-large healthcare facilities and durable medical equipment distributors who partner with manufacturers like 3M, GOJO, and Cantel for broader penetration.